Timely identification of newborns exposed to both opioids and gabapentin during pregnancy could mean more appropriate care for newborns experiencing withdrawal, according to researchers at Marshall University, in collaboration with Marshall Health, Cabell Huntington Hospital and the Centers for Disease Control and Prevention.
from News-Medical.Net Child Health News Feed https://ift.tt/36ZgFLL
0 Comments